{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:03:39Z","timestamp":1780041819912,"version":"3.53.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1191292"],"award-info":[{"award-number":["GNT1191292"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001036","name":"Australian Rotary Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019999","name":"Trish Multiple Sclerosis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.msard.2025.106635","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:58:28Z","timestamp":1753142308000},"page":"106635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A single nucleotide polymorphism in the MerTK gene is associated with increased radiological disease activity in patients with multiple sclerosis on natalizumab therapy"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8724-0538","authenticated-orcid":false,"given":"Melissa Minhui","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kalincik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rui","family":"Seet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2025.106635_bib0002","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106635_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111807","article-title":"The Gas6\/TAM system and multiple sclerosis","volume":"17","author":"Bellan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2025.106635_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005853","article-title":"Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status","volume":"12","author":"Binder","year":"2016","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.msard.2025.106635_bib0012","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200190","article-title":"HLA-DRB1*15:01 and the MERTK gene interact to selectively influence the profile of MERTK-expressing monocytes in both health and MS","volume":"11","author":"Binder","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2025.106635_bib0023","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1189\/jlb.3A0714-334R","article-title":"MERTK as negative regulator of human T cell activation","volume":"97","author":"Cabezon","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"549","key":"10.1016\/j.msard.2025.106635_bib0006","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aar3721","article-title":"Tabas I. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity","volume":"11","author":"Cai","year":"2018","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.msard.2025.106635_bib0008","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/jpet.112.199778","article-title":"Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation","volume":"344","author":"Choi","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"365","key":"10.1016\/j.msard.2025.106635_bib0009","doi-asserted-by":"crossref","first-page":"ra21","DOI":"10.1126\/scisignal.2005864","article-title":"Mer signaling increases the abundance of the transcription factor LXR to promote the resolution of acute sterile inflammation","volume":"8","author":"Choi","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.msard.2025.106635_bib0018","series-title":"R: A Language and Environment for Statistical Computing","author":"Development Core Team","year":"2022"},{"issue":"8","key":"10.1016\/j.msard.2025.106635_bib0019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamaneurol.2024.1961","article-title":"Acute clinical events identified as relapses with stable magnetic resonance imaging in multiple sclerosis","volume":"81","author":"Gavoille","year":"2024","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106635_bib0022","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1212\/NXI.0000000000000402","article-title":"MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS","volume":"4","author":"Healy","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2025.106635_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.msard.2025.106635_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(94)00165-K","article-title":"A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis","volume":"58","author":"Kent","year":"1995","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106635_bib0014","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.181.1.381","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12","volume":"181","author":"Leonard","year":"1995","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.msard.2025.106635_bib0001","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106635_bib0015","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1530\/VB-19-0033","article-title":"Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation","volume":"2","author":"Marchetti","year":"2020","journal-title":"Vasc. Biol."},{"issue":"9","key":"10.1016\/j.msard.2025.106635_bib0024","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/2326-6066.CIR-18-0841","article-title":"MERTK acts as a costimulatory receptor on human CD8(+) T cells","volume":"7","author":"Peeters","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.msard.2025.106635_bib0020","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"issue":"7359","key":"10.1016\/j.msard.2025.106635_bib0003","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106635_bib0017","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","article-title":"Problems of experimental trials of therapy in Multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in Multiple sclerosis","volume":"122","author":"Schumacher","year":"1965","journal-title":"Ann. N. Acad. Sci."},{"key":"10.1016\/j.msard.2025.106635_bib0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2018.03.002","article-title":"The role of TAM family receptors and ligands in the nervous system: from development to pathobiology","volume":"188","author":"Shafit-Zagardo","year":"2018","journal-title":"Pharmacol. Ther"},{"issue":"10","key":"10.1016\/j.msard.2025.106635_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108835","article-title":"Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination","volume":"34","author":"Shen","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.msard.2025.106635_bib0016","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106635_bib0007","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1172\/JCI97354","article-title":"Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response","volume":"128","author":"Ubil","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.msard.2025.106635_bib0021","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41419-021-03770-0","article-title":"Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages","volume":"12","author":"Wanke","year":"2021","journal-title":"Cell Death Dis."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:22:02Z","timestamp":1780039322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825003773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"alternative-id":["S2211034825003773"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106635","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single nucleotide polymorphism in the MerTK gene is associated with increased radiological disease activity in patients with multiple sclerosis on natalizumab therapy","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106635"}}